|||
找到的结果数: | 8584 |
被引频次总计: | 262353 |
去除自引的被引频次总计: | 231187 |
施引文献: | 132956 |
去除自引的施引文献: | 126589 |
每项平均引用次数: | 30.56 |
h-index : | 187 |
字段: 作者 | 记录 计数 | %,共 8584 | 柱状图 | 表格中显示的数据行 所有数据行 |
---|---|---|---|---|
GOLDENBERG DM | 95 | 1.107 % | ||
DENARDO SJ | 53 | 0.617 % | ||
BASELGA J | 52 | 0.606 % | ||
BUCHSBAUM DJ | 52 | 0.606 % | ||
DENARDO GL | 49 | 0.571 % | ||
SHARKEY RM | 46 | 0.536 % | ||
HICKLIN DJ | 44 | 0.513 % | ||
PASTAN I | 42 | 0.489 % | ||
CIARDIELLO F | 41 | 0.478 % | ||
SCHLOM J | 40 | 0.466 % |
字段: 国家/地区 | 记录 计数 | %,共 8584 | 柱状图 | 表格中显示的数据行 所有数据行 |
---|---|---|---|---|
USA | 4235 | 49.336 % | ||
GERMANY | 976 | 11.370 % | ||
JAPAN | 723 | 8.423 % | ||
ENGLAND | 643 | 7.491 % | ||
ITALY | 624 | 7.269 % | ||
FRANCE | 449 | 5.231 % | ||
CANADA | 327 | 3.809 % | ||
NETHERLANDS | 315 | 3.670 % | ||
PEOPLES R CHINA | 291 | 3.390 % | ||
SWITZERLAND | 231 | 2.691 % |
字段: 基金资助机构 | 记录 计数 | %,共 8584 | 柱状图 | 表格中显示的数据行 所有数据行 |
---|---|---|---|---|
NIH | 194 | 2.260 % | ||
NATIONAL CANCER INSTITUTE | 107 | 1.247 % | ||
NATIONAL INSTITUTES OF HEALTH | 55 | 0.641 % | ||
NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA | 44 | 0.513 % | ||
PFIZER | 37 | 0.431 % | ||
GENENTECH | 33 | 0.384 % | ||
ROCHE | 32 | 0.373 % | ||
BRISTOL MYERS SQUIBB | 29 | 0.338 % | ||
GLAXOSMITHKLINE | 29 | 0.338 % | ||
NOVARTIS | 29 | 0.338 % | ||
AMERICAN CANCER SOCIETY | 28 | 0.326 % | ||
DEPARTMENT OF DEFENSE | 26 | 0.303 % | ||
GENENTECH INC | 25 | 0.291 % | ||
NCI | 24 | 0.280 % | ||
PFIZER INC | 24 | 0.280 % | ||
SANOFI AVENTIS | 23 | 0.268 % | ||
AMGEN | 21 | 0.245 % | ||
ASTRAZENECA | 20 | 0.233 % | ||
CANCER RESEARCH UK | 20 | 0.233 % | ||
EUROPEAN UNION | 20 | 0.233 % | ||
NIH NCI | 20 | 0.233 % | ||
BREAST CANCER RESEARCH FOUNDATION | 19 | 0.221 % | ||
DEUTSCHE FORSCHUNGSGEMEINSCHAFT | 18 | 0.210 % | ||
MERCK | 17 | 0.198 % | ||
EU | 16 | 0.186 % |
字段: 机构 | 记录 计数 | %,共 8584 | 柱状图 | 表格中显示的数据行 所有数据行 |
---|---|---|---|---|
UNIV TEXAS | 347 | 4.042 % | ||
NCI | 314 | 3.658 % | ||
MEM SLOAN KETTERING CANC CTR | 261 | 3.041 % | ||
HARVARD UNIV | 180 | 2.097 % | ||
UNIV CALIF LOS ANGELES | 157 | 1.829 % | ||
UNIV ALABAMA | 150 | 1.747 % | ||
UNIV TEXAS MD ANDERSON CANC CTR | 150 | 1.747 % | ||
UNIV CALIF SAN FRANCISCO | 123 | 1.433 % | ||
UNIV PITTSBURGH | 112 | 1.305 % | ||
DUKE UNIV | 110 | 1.281 % | ||
UNIV MUNICH | 97 | 1.130 % | ||
GENENTECH INC | 93 | 1.083 % | ||
DANA FARBER CANC INST | 89 | 1.037 % | ||
MAYO CLIN | 86 | 1.002 % | ||
UNIV WISCONSIN | 86 | 1.002 % | ||
UNIV CALIF DAVIS | 85 | 0.990 % | ||
FOX CHASE CANC CTR | 84 | 0.979 % | ||
MASSACHUSETTS GEN HOSP | 81 | 0.944 % | ||
UNIV SO CALIF | 79 | 0.920 % | ||
UNIV TORONTO | 78 | 0.909 % | ||
VANDERBILT UNIV | 77 | 0.897 % | ||
UNIV MICHIGAN | 76 | 0.885 % | ||
STANFORD UNIV | 75 | 0.874 % | ||
CORNELL UNIV | 72 | 0.839 % | ||
ROSWELL PK CANC INST | 71 | 0.827 % |
字段: 出版年 | 记录 计数 | %,共 8584 | 柱状图 | 表格中显示的数据行 所有数据行 |
---|---|---|---|---|
2010 | 808 | 9.413 % | ||
2009 | 729 | 8.493 % | ||
2008 | 713 | 8.306 % | ||
2011 | 712 | 8.295 % | ||
2007 | 681 | 7.933 % | ||
2006 | 571 | 6.652 % | ||
2005 | 500 | 5.825 % | ||
2004 | 479 | 5.580 % | ||
2003 | 399 | 4.648 % | ||
2001 | 358 | 4.171 % | ||
2002 | 351 | 4.089 % | ||
2000 | 308 | 3.588 % | ||
1999 | 299 | 3.483 % | ||
1997 | 237 | 2.761 % | ||
1996 | 230 | 2.679 % | ||
1998 | 230 | 2.679 % | ||
1994 | 201 | 2.342 % | ||
1995 | 182 | 2.120 % | ||
1993 | 162 | 1.887 % | ||
2012 | 161 | 1.876 % | ||
1991 | 134 | 1.561 % | ||
1992 | 115 | 1.340 % | ||
1990 | 13 | 0.151 % | ||
1985 | 3 | 0.035 % | ||
1986 | 2 | 0.023 % |
字段: 来源出版物 | 记录 计数 | %,共 8584 | 柱状图 | 表格中显示的数据行 所有数据行 |
---|---|---|---|---|
CLINICAL CANCER RESEARCH | 795 | 9.261 % | ||
CANCER RESEARCH | 667 | 7.770 % | ||
CANCER | 356 | 4.147 % | ||
JOURNAL OF CLINICAL ONCOLOGY | 345 | 4.019 % | ||
INTERNATIONAL JOURNAL OF CANCER | 343 | 3.996 % | ||
BRITISH JOURNAL OF CANCER | 323 | 3.763 % | ||
ANTICANCER RESEARCH | 275 | 3.204 % | ||
CANCER IMMUNOLOGY IMMUNOTHERAPY | 269 | 3.134 % | ||
INTERNATIONAL JOURNAL OF ONCOLOGY | 167 | 1.945 % | ||
MOLECULAR CANCER THERAPEUTICS | 163 | 1.899 % | ||
ANNALS OF ONCOLOGY | 161 | 1.876 % | ||
EUROPEAN JOURNAL OF CANCER | 158 | 1.841 % | ||
BREAST CANCER RESEARCH AND TREATMENT | 137 | 1.596 % | ||
JOURNAL OF IMMUNOTHERAPY | 133 | 1.549 % | ||
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 126 | 1.468 % | ||
CANCER GENE THERAPY | 118 | 1.375 % | ||
ONCOLOGIST | 115 | 1.340 % | ||
ONCOLOGY REPORTS | 115 | 1.340 % | ||
ONCOGENE | 112 | 1.305 % | ||
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 111 | 1.293 % | ||
GYNECOLOGIC ONCOLOGY | 108 | 1.258 % | ||
CANCER BIOLOGY THERAPY | 99 | 1.153 % | ||
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 87 | 1.014 % | ||
CANCER LETTERS | 79 | 0.920 % | ||
CANCER SCIENCE | 79 | 0.920 % |
字段: 学科类别 | 记录 计数 | %,共 8584 | 柱状图 | 表格中显示的数据行 所有数据行 |
---|---|---|---|---|
ONCOLOGY | 8584 | 100.000 % | ||
IMMUNOLOGY | 462 | 5.382 % | ||
RESEARCH EXPERIMENTAL MEDICINE | 404 | 4.706 % | ||
PHARMACOLOGY PHARMACY | 380 | 4.427 % | ||
RADIOLOGY NUCLEAR MEDICINE MEDICAL IMAGING | 296 | 3.448 % | ||
HEMATOLOGY | 295 | 3.437 % | ||
GENETICS HEREDITY | 242 | 2.819 % | ||
OBSTETRICS GYNECOLOGY | 215 | 2.505 % | ||
CELL BIOLOGY | 203 | 2.365 % | ||
BIOCHEMISTRY MOLECULAR BIOLOGY | 172 | 2.004 % | ||
BIOTECHNOLOGY APPLIED MICROBIOLOGY | 167 | 1.945 % | ||
SURGERY | 137 | 1.596 % | ||
PATHOLOGY | 78 | 0.909 % | ||
RESPIRATORY SYSTEM | 74 | 0.862 % | ||
PEDIATRICS | 66 | 0.769 % | ||
NEUROSCIENCES NEUROLOGY | 53 | 0.617 % | ||
BIOPHYSICS | 38 | 0.443 % | ||
ENDOCRINOLOGY METABOLISM | 32 | 0.373 % | ||
UROLOGY NEPHROLOGY | 27 | 0.315 % | ||
DENTISTRY ORAL SURGERY MEDICINE | 23 | 0.268 % | ||
DERMATOLOGY | 23 | 0.268 % | ||
TRANSPLANTATION | 16 | 0.186 % | ||
NURSING | 14 | 0.163 % | ||
HEALTH CARE SCIENCES SERVICES | 13 | 0.151 % | ||
REHABILITATION | 13 | 0.151 % |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-9-28 01:18
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社